EUVIMEDEUVIMED entdecken
Open Access

The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma

Liang Zeng, Ying-Qing Li, Shi-Wei He, Hui Xu, Ruizhong Zhang, Kai Chen, Liang-Jun Qin, Xun-Hua Zhu, Yi-Lin Li, Le Li, Na Liu iD, Hai-Yun Wang iD

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noae175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Liang Zeng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center f…. Hauptthemen laut MEDLINE: Neuroblastoma, Cisplatin, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the National Natural Science Foundation of China, the Department of Science and Technology of Guangdong Province, Guangzhou Women and Children's Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dysregulated deubiquitinating enzymes (DUBs) execute as intrinsic oncogenes or tumor suppressors and are involved in chemoresistance in cancers. However, the functions and exact molecular mechanisms remain largely unclear in neuroblastoma.

Methods

Here, an R2 screening strategy based on the standard deviation values was used to identify the most important DUB, USP44, in neuroblastoma with stage 4. We validated the role of USP44 regulation upon cisplatin treatment in vitro and in vivo experiments, revealing the molecular mechanisms associated with USP44 regulation and cisplatin sensitivity in neuroblastoma.

Results

We found that low USP44 expression was associated with an inferior prognosis in neuroblastoma patients. Overexpression of USP44 enhanced neuroblastoma cell sensitivity to cisplatin in vitro and in vivo. Mechanistically, USP44 recruited and stabilized the E3 ubiquitin ligase STUB1 by removing its K48-linked polyubiquitin chains at Lys30, and STUB1 further reinforced the K48-linked polyubiquitination of LRPPRC at Lys453 and promoted its protein degradation, thus enhancing the accumulation of mitochondrial reactive oxygen species (mROS), in turn facilitating neuroblastoma cell apoptosis and cisplatin sensitivity. Additionally, overexpression of LRPPRC reversed the promoting effect of USP44 on cell apoptosis in cisplatin-treated neuroblastoma cells.

Conclusions

Our findings demonstrate that the USP44–STUB1–LRPPRC axis plays a pivotal role in neuroblastoma chemoresistance and provides potential targets for neuroblastoma therapy and prognostication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaCisplatinUbiquitin ThiolesteraseUbiquitin-Protein LigasesDrug Resistance, NeoplasmAntineoplastic AgentsHumansAnimalsMiceApoptosisPrognosisProteolysisXenograft Model Antitumor AssaysMice, NudeCell ProliferationTumor Cells, CulturedUbiquitinationFemaleCell Line, Tumor

Stichwörter der Autor:innen

USP44chemoresistanceneuroblastomaubiquitination

Substanzen

CisplatinUbiquitin ThiolesteraseUbiquitin-Protein LigasesUSP44 protein, humanSTUB1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children's Medical Center for South Central…
  • Department of Experimental Research, State Key Laboratory of Oncology in Southern China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Guangdong Provincial Key Laboratory of Research in Structure Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, P. R. China.
  • Department of Breast and Thyroid Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, P. R. China.
  • Department of Thoracic Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, National Children's Medical Center for South C…
  • Guangzhou Institute of Paediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, National Children's Medical Center for South Central Region, Guangzhou, P. R. China.

ORCID-Profile: Na Liu, Hai-Yun Wang

Förderung

  • the National Natural Science Foundation of China
  • the Department of Science and Technology of Guangdong Province
  • Guangzhou Women and Children's Medical Center
  • Guangzhou Women and Children’s Medical Center

Zitieren

APA

Zeng, L., Li, Y. Q., He, S. W., Xu, H., Zhang, R., Chen, K., Qin, L. J., Zhu, X. H., Li, Y. L., Li, L., Liu, N., & Wang, H. Y. (2025). The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae175

Vancouver

Zeng L, Li YQ, He SW, Xu H, Zhang R, Chen K, et al. The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. Neuro-Oncology. 2025. doi:10.1093/neuonc/noae175

BibTeX
@article{Zeng2025,
  author = {Zeng, Liang and Li, Ying-Qing and He, Shi-Wei and Xu, Hui and Zhang, Ruizhong and Chen, Kai and Qin, Liang-Jun and Zhu, Xun-Hua and Li, Yi-Lin and Li, Le and Liu, Na and Wang, Hai-Yun},
  title = {The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noae175}
}
Kostenlos starten →